The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis.
Ka ZhangHaixia SunHuijuan CaoYifan JiaXin ShuHong CaoYufeng ZhangXiaoan YangPublished in: Stem cell research & therapy (2021)
The therapeutic effects of UCMSCs for HBV-related acute-on-chronic liver failure and liver cirrhosis varied partly by patient age. Assessing patient age is necessary prior to UCMSC clinical use.